BioSpace News Archive

Seqirus, a global leader in influenza prevention and influenza pandemic response, today announced new late-breaking data from a systematic review and meta-analysis presented at the European Scientific Working Group on Influenza (ESWI) virtual conference confirming the benefit of an MF59®-adjuvanted trivalent seasonal influenza vaccine (aTIV) for adults 65 years and older

Slayback Pharma LLC (“Slayback”) announced today the appointment of Dr Sumitra Pillai as Vice President and the new Head of R&D.

INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has dosed its first subject in a Phase 2 clinical trial evaluating DNA medicine INO-4800, its COVID-19 vaccine candidate,

Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced it has expanded its presence in the Dallas-Fort Worth metroplex through its partnership with Mesquite | DeSoto Dermatology.

Significant gaps in education and communication among patients and physicians pose barriers to lupus nephritis care, according to results of two companion surveys conducted by the National Kidney Foundation and the Lupus Research Alliance.

CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical firm focused on research and development for the oncology and neurodegenerative disease categories, today highlighted that Orphazyme A/S (NASDAQ: ORPH) (“Orphazyme”) has announced the expansion of its U.S. presence and workforce ahead of potential Food and Drug Administration (“FDA”) approval of arimoclomol for the treatment of Niemann-Pick disease Type C (“NPC”).

AireHealth, an innovative digital health company empowering and improving healthy living through affordable treatments, symptom tracking and early detection of respiratory conditions, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its connected nebulizer

Researchers from Case Western Reserve University presented research Saturday in which Hemex Health’s Gazelle platform diagnostic technology successfully tested 46 patients with 100% sensitivity and over 92.3% specificity for anemia and with 100% accuracy for hemoglobin variants.

Katena Products (“Katena”), a leading provider of ophthalmic instruments, biologics, and devices, is pleased to announce that Steve Blazejewski has joined as Chief Executive Officer.

Presentation at Virtual ASH Annual Meeting found treatment with ropeginterferon alfa-2b at five years reduced drivers of disease progression, including allelic burden